Deborah V. Davis Ascheim MD
Heart Failure & Transplantation
Professor, Population Heallth Science & Policy / Medicine (Cardiology), Icahn School of Medicine at Mount Sinai
Join to View Full Profile
5 E 98th St3rd FloorNew York, NY 10029
Phone+1 212-427-1540
Fax+1 212-410-7196
Dr. Ascheim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital(Cornell Campus)/Coney Island HospitalFellowship, Cardiovascular Disease, 1993 - 1996- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1990 - 1993
New York University School of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 2015 - 2026
NY State Medical License 1992 - 2025
Clinical Trials
- Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD Start of enrollment: 2009 Aug 01
- Hybrid Revascularization Observational Study Start of enrollment: 2010 May 01
- The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in Patients Undergoing LVAD Implantation Start of enrollment: 2012 Apr 01
Publications & Presentations
PubMed
- 38 citationsRepeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled,...Craig M McDonald, Eduardo Marbán, Suzanne Hendrix, Nathaniel Hogan, Rachel Ruckdeschel Smith
Lancet. 2022-03-12 - 7 citationsRisk for non-home discharge following surgery for ischemic mitral valve disease.Anuradha Lala, Helena L. Chang, Xiaoyu Liu, Eric J. Charles, Babatunde A. Yerokun
The Journal of Thoracic and Cardiovascular Surgery. 2021-12-01 - 11 citationsEffect of cardiosphere-derived cells on segmental myocardial function after myocardial infarction: ALLSTAR randomised clinical trial.Mohammad R. Ostovaneh, Raj Makkar, Bharath Ambale-Venkatesh, Deborah D. Ascheim, Tarun Chakravarty
Open Heart. 2021-07-01
Press Mentions
CIRM $4 Million Awarded to Support Innovative Gene Therapy for Rare Heart DisorderSeptember 16th, 2024- Rejuvenate Bio Appoints Deborah Ascheim, M.D., as Chief Medical OfficerJanuary 3rd, 2023
- Genentech Alum Jane Grogan Goes Startup Hopping from ArsenalBio to Graphite Bio; Scott Holmes to Handle CFO Duties at Catamaran Bio, Teaming up Again with Ex-Disarm CEOApril 30th, 2021
Committees
- member, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
